Scott E Woodman

Scott E Woodman

UNVERIFIED PROFILE

Are you Scott E Woodman?   Register this Author

Register author
Scott E Woodman

Scott E Woodman

Publications by authors named "Scott E Woodman"

Are you Scott E Woodman?   Register this Author

67Publications

2713Reads

7Profile Views

Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma.

J Invest Dermatol 2019 Mar 25;139(3):728-731. Epub 2018 Oct 25.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.10.009DOI Listing
March 2019

Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma.

JCO Precis Oncol 2018 5;2018. Epub 2018 Jun 5.

Junna Oba, Sun-Hee Kim, Wei-Lien Wang, Mariana P. Macedo, Fernando Carapeto, Meredith A McKean, John Van Arnam, Agda K. Eterovic, Shiraj Sen, Charuta R. Kale, Xiaoxing Yu, Cara L. Haymaker, Mark Routbort, Lauren E. Haydu, Chantale Bernatchez, Alexander J. Lazar, Elizabeth A. Grimm, David S. Hong, and Scott E. Woodman, The University of Texas MD Anderson Cancer Center, Houston, TX; and Mariana P. Macedo, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080631PMC
http://dx.doi.org/10.1200/PO.18.00055DOI Listing
June 2018

Uveal Melanoma: Identifying Immunological and Chemotherapeutic Targets to Treat Metastases.

Asia Pac J Ophthalmol (Phila) 2017 Mar-Apr;6(2):179-185

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.22608/APO.201782DOI Listing
September 2017

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.

Cell 2016 Oct 22;167(2):397-404.e9. Epub 2016 Sep 22.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088716PMC
http://dx.doi.org/10.1016/j.cell.2016.08.069DOI Listing
October 2016

Uveal melanoma: From diagnosis to treatment and the science in between.

Cancer 2016 08 15;122(15):2299-312. Epub 2016 Mar 15.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29727DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567680PMC
August 2016

ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma.

Cancer Cell 2016 06 2;29(6):889-904. Epub 2016 Jun 2.

Department of Medicine, Program in Molecular Medicine, University of Utah, 15 North 2030 East, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA; Department of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA; ARUP Laboratories, University of Utah, Salt Lake City, UT 84112, USA; Key Laboratory for Human Disease Gene Study, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu 610072, China; Division of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA; Department of Cardiology, VA Salt Lake City Health Care System, Salt Lake City, UT 84112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.04.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027844PMC
June 2016

Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in Melanoma.

Clin Cancer Res 2016 Jan 25;22(2):374-82. Epub 2015 Aug 25.

Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821426PMC
January 2016

Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.

Sci Rep 2016 Jan 20;6:19649. Epub 2016 Jan 20.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep19649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726397PMC
January 2016

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

Cancer Cell 2015 Oct 1;28(4):515-528. Epub 2015 Oct 1.

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108150030
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2015.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605878PMC
October 2015

Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.

Pigment Cell Melanoma Res 2015 May 23;28(3):357-9. Epub 2015 Mar 23.

Department of Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA; Systems Biology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12345DOI Listing
May 2015

HotSpotter: efficient visualization of driver mutations.

BMC Genomics 2014 Dec 1;15:1044. Epub 2014 Dec 1.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 7455 Fannin St, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-15-1044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265503PMC
December 2014

Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration.

PLoS One 2014 13;9(2):e83957. Epub 2014 Feb 13.

Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America ; Systems Biology, University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083957PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923717PMC
October 2014

RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?

Cancer Discov 2014 Sep;4(9):988-90

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-0738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155513PMC
September 2014

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma.

Melanoma Res 2014 Aug;24(4):342-8

aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278368PMC
August 2014

Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.

Blood 2012 Nov 30;120(23):4533-43. Epub 2012 Aug 30.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-02-407163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512233PMC
November 2012

BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.

J Cutan Pathol 2012 Sep 19;39(9):821-5. Epub 2012 Jul 19.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0560.2012.01950.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881367PMC
September 2012

Metastatic uveal melanoma: biology and emerging treatments.

Authors:
Scott E Woodman

Cancer J 2012 Mar-Apr;18(2):148-52

Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00130404-201203000-000
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e31824bd256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935729PMC
July 2012

Profile of ipilimumab and its role in the treatment of metastatic melanoma.

Drug Des Devel Ther 2011 16;5:489-95. Epub 2011 Dec 16.

Melanoma Medical Oncology, Department, University of Texas, MD Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S10945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257959PMC
May 2012

New strategies in melanoma: molecular testing in advanced disease.

Clin Cancer Res 2012 Mar 24;18(5):1195-200. Epub 2012 Jan 24.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2317DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109407PMC
March 2012

BAP1tism of a tumor suppressor.

Authors:
Scott E Woodman

Clin Cancer Res 2012 Jan 2;18(2):323-5. Epub 2011 Dec 2.

Departments of Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-2870DOI Listing
January 2012

Are oncogenes sufficient to cause human cancer?

Proc Natl Acad Sci U S A 2010 Nov 17;107(48):20599-600. Epub 2010 Nov 17.

Melanoma Medical Oncology, Systems Biology, Kleberg Center for Molecular Markers, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1015563107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996413PMC
November 2010

Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.

Biochem Pharmacol 2010 Sep 8;80(5):568-74. Epub 2010 May 8.

Departments of Melanoma Medical Oncology and Systems Biology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2010.04.032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935736PMC
September 2010

Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.

Clin Cancer Res 2009 Dec;15(24):7538-7546

Authors' Affiliations: Departments of Melanoma Medical Oncology, Systems Biology, Biostatistics, Cancer Medicine, Surgical Oncology, Cancer Biology, and Pathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas; and Lovelace Respiratory Research Institute, Albuquerque, New Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805170PMC
December 2009

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.

Nat Clin Pract Oncol 2008 Dec 21;5(12):737-40. Epub 2008 Oct 21.

Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc1251DOI Listing
December 2008

MR imaging of caveolin gene-specific alterations in right ventricular wall thickness.

Magn Reson Imaging 2005 Jan;23(1):61-8

Department of Physiology and Biophysics, Albert Einstein College of Medicine and Montefiore Medical Center. Bronx, NY 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mri.2004.11.011DOI Listing
January 2005

Urogenital alterations in aged male caveolin-1 knockout mice.

J Urol 2004 Feb;171(2 Pt 1):950-7

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ju.0000105102.72295.b8DOI Listing
February 2004

Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.

Am J Physiol Cell Physiol 2003 Nov 2;285(5):C1150-60. Epub 2003 Jul 2.

Department of Molecular Pharmacology, The Albert Einstein Cancer Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpcell.00166.2003DOI Listing
November 2003

Caveolin, caveolae, and endothelial cell function.

Arterioscler Thromb Vasc Biol 2003 Jul 10;23(7):1161-8. Epub 2003 Apr 10.

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.ATV.0000070546.16946.3ADOI Listing
July 2003

Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli.

Am J Pathol 2003 Jun;162(6):2059-68

Department of Molecular Pharmacology, Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868145PMC
http://dx.doi.org/10.1016/S0002-9440(10)64337-4DOI Listing
June 2003

Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.

J Biol Chem 2002 Oct 23;277(41):38988-97. Epub 2002 Jul 23.

Department of Molecular Pharmacology, Division of Hormone-Dependent Tumor Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M205511200DOI Listing
October 2002

Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.

J Biol Chem 2002 Oct 7;277(42):40091-8. Epub 2002 Aug 7.

Department of Molecular Pharmacology, the Division of Hormone-Dependent Tumor Biology at the Albert Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M205948200
Publisher Site
http://dx.doi.org/10.1074/jbc.M205948200DOI Listing
October 2002

Caveolae: from cell biology to animal physiology.

Pharmacol Rev 2002 Sep;54(3):431-67

Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, New York 10461, USA.

View Article

Download full-text PDF

Source
https://pdfs.semanticscholar.org/d87e/a0514973a91e49272abbfa
Web Search
http://dx.doi.org/10.1124/pr.54.3.431DOI Listing
September 2002

Mutational analysis identifies a short atypical membrane attachment sequence (KYWFYR) within caveolin-1.

Biochemistry 2002 Mar;41(11):3790-5

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi0120751DOI Listing
March 2002